We are live on
!
Find out more
Qube Research & Technologies (QRT) Portfolio holdings
AUM
$89.9B
1-Year Est. Return
20.22%
This Fund
S&P 500
This Quarter
Est. Return
+2.03%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
–
AUM
$23.2B
AUM Growth
+$4.57B
(+24%)
Cap. Flow
+$4.34B
Cap. Flow
% of AUM
18.68%
Top 10 Holdings %
Top 10 Hldgs %
24.47%
Holding
3,215
New
812
Increased
777
Reduced
812
Closed
734
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRC
First Republic Bank
FRC
|
+$286M |
| 2 |
Cigna
CI
|
+$183M |
| 3 |
Honeywell
HON
|
+$156M |
| 4 |
ConocoPhillips
COP
|
+$150M |
| 5 |
Abbott
ABT
|
+$120M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$180M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$123M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$116M |
| 4 |
CME Group
CME
|
+$115M |
| 5 |
Texas Instruments
TXN
|
+$110M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.38% |
| 2 | Consumer Discretionary | 11.26% |
| 3 | Healthcare | 10.95% |
| 4 | Financials | 10.85% |
| 5 | Industrials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
Dimensional World ex US Core Equity 2 ETF
DFAX
$11.9B
| $667K | ﹤0.01% |
28,917
+28,571
| +8,258% | +$653K |
|
|
ILPT
1452
Industrial Logistics Properties Trust
ILPT
$565M
| $666K | ﹤0.01% |
217,076
+65,972
| +44% | +$258K |
|
|
HQH
1453
abrdn Healthcare Investors
HQH
$1.26B
| $666K | ﹤0.01% |
37,717
+2,500
| +7% | +$45.5K |
|
1454
Brookfield Infrastructure
BIPC
$5.24B
| $664K | ﹤0.01% |
14,420
-45,019
| -76% | -$1.96M |
|
1455
TFI International
TFII
$11B
| $661K | ﹤0.01% |
+5,539
| New | +$645K |
|
1456
Relay Therapeutics
RLAY
$4.24B
| $660K | ﹤0.01% |
40,079
-2,523
| -6% | -$45.2K |
|
1457
Barrett Business Services
BBSI
$982M
| $659K | ﹤0.01% |
+29,752
| New | +$695K |
|
|
JOYY
1458
JOYY Inc
JOYY
$3.68B
| $659K | ﹤0.01% |
21,140
-95,871
| -82% | -$3.23M |
|
1459
iShares Core US Aggregate Bond ETF
AGG
$138B
| $658K | ﹤0.01% |
6,600
-3,636
| -36% | -$359K |
|
|
IIF
1460
Morgan Stanley India Investment Fund
IIF
$217M
| $657K | ﹤0.01% |
33,749
+5,000
| +17% | +$100K |
|
1461
Immersion
IMMR
$246M
| $651K | ﹤0.01% |
72,852
+32,020
| +78% | +$242K |
|
1462
Gabelli Equity Trust
GAB
$1.76B
| $651K | ﹤0.01% |
113,336
+48,185
| +74% | +$276K |
|
1463
Teekay
TK
$983M
| $649K | ﹤0.01% |
+105,094
| New | +$562K |
|
|
GATO
1464
DELISTED
Gatos Silver, Inc.
GATO
| $649K | ﹤0.01% |
99,446
+88,300
| +792% | +$425K |
|
1465
Corcept Therapeutics
CORT
$12.8B
| $645K | ﹤0.01% |
29,801
-106,963
| -78% | -$2.34M |
|
1466
Alight
ALIT
$481M
| $644K | ﹤0.01% |
+3,498
| New | +$642K |
|
1467
First Trust Capital Strength ETF
FTCS
$7.95B
| $637K | ﹤0.01% |
8,733
-2,195
| -20% | -$162K |
|
1468
Organogenesis Holdings
ORGO
$315M
| $635K | ﹤0.01% |
298,046
+236,884
| +387% | +$585K |
|
1469
Voyager Therapeutics
VYGR
$189M
| $635K | ﹤0.01% |
82,326
+52,504
| +176% | +$418K |
|
1470
Trustmark
TRMK
$2.77B
| $635K | ﹤0.01% |
+25,694
| New | +$759K |
|
1471
State Street SPDR Portfolio Intermediate Term Treasury ETF
SPTI
$10.5B
| $634K | ﹤0.01% |
+21,906
| New | +$626K |
|
1472
Enanta Pharmaceuticals
ENTA
$378M
| $633K | ﹤0.01% |
15,654
-7,742
| -33% | -$370K |
|
|
LUNA
1473
DELISTED
Luna Innovations Incorporated
LUNA
| $633K | ﹤0.01% |
88,005
+57,006
| +184% | +$503K |
|
1474
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.1B
| $632K | ﹤0.01% |
18,532
-8,202
| -31% | -$282K |
|
1475
Nicolet Bankshares
NIC
$3.57B
| $629K | ﹤0.01% |
9,978
+2,207
| +28% | +$159K |
|
Similar funds
Qube Research & Technologies (QRT)'s Q1 2023 Portfolio in Review
As of Q1 2023, Qube Research & Technologies (QRT) held 3,215 positions worth $23.2B, up 24% from $18.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Qube Research & Technologies (QRT) deployed $4.34B of net new capital in Q1 2023, opening 812 new positions and adding to 777 existing holdings. Its largest new stake was First Republic Bank: 2,786,874 shares worth $39M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $180M trimmed.
- Qube Research & Technologies (QRT)'s largest Q1 2023 buy was First Republic Bank: 2,786,874 shares worth $39M.
- Qube Research & Technologies (QRT) added most to Cigna in Q1 2023, an estimated $183M increase.
- Qube Research & Technologies (QRT)'s biggest Q1 2023 reduction was Apple, cutting an estimated $180M.
- Qube Research & Technologies (QRT) fully exited Vertex Pharmaceuticals in Q1 2023, selling an estimated $123M.
- Qube Research & Technologies (QRT)'s ten largest holdings make up 24% of its $23.2B portfolio in Q1 2023.
- Qube Research & Technologies (QRT) opened 812 new positions and closed 734 in Q1 2023.
- Qube Research & Technologies (QRT)'s portfolio value rose 24% quarter-over-quarter to $23.2B.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2023, filed 15 May 2023.